The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is 30.00 USD. With the latest stock price at 19.89 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is 50.8%.
Based on the latest price of 19.89 USD and our DCF valuation, ACADIA Pharmaceuticals Inc (ACAD) is a buy. buying Acadia stocks now will result in a potential gain of 50.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.4% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 17.41 - 250.09 | 30.00 |
| Upside | -12.5% - 1157.4% | 50.8% |